Intestinal lymphangiectasia: case report

Reham Mohmmad Aljohnei, Hawazen Yousef Abdullah Alani


Primary intestinal lymphangiectasia (PIL) was first described by Waldmann et al, in 1961. PIL is a rare disease with several hundred reported cases. It is rarely reported in adults because it is presumably a congenital disorder and when present in adults it typically produces a long duration of manifestation such as diarrhea, abdominal distention from ascites, and peripheral edema. This disorder is characterized by markedly dilated intestinal lymphatics, hypoproteinemia, generalized edema, lymphocytopenia hypogammaglobinemia, and immunologic anomalies. The loss of protein into the from dilated intestinal lymphatics leads to the development of hypoproteinemia in these patients and its demonstration is important in the diagnosis of intestinal lymphangiectasia. The disease can be secondary to congenital, secondary or idiopathic defects in the formation of the lymphatic ducts. In the present report, we describe a case of 15 years old female presented to our hospital with history of generalized edema, bilateral hand spasm, and diarrhea. Endoscopy of the patient revealed White spots (dilated lacteals), white nodules, and submucosal elevations were observed. Changes suggestive of the disease includes White villi and/or spots (dilated lacteals), white nodules, and submucosal elevations are observed. Xanthomata’s plaques are often visualized, there are no specific treatments for patients with PIL. treatment of patients with primary intestinal lymphangiectasia involves control of symptoms with the use of dietary, pharmaceutical, and behavioral modifications.


Dietary, Intestinal, Lymphangiectasia, Rare, Villi

Full Text:



Waldmann TA, Steinfeld JL, Dutcher TF, Davidson JD, Gordon RS. Jr. The Role of the Gastrointestinal System in; Idiopathic Hypoproteinemia. Gastroenterol. 1961;41(3):197-207.

Alshikho MJ, Talas JM, Noureldine SI, Zazou S, Addas A, Kurabi H, et al. Intestinal Lymphangiectasia: Insights on Management and Literature Review. Am J Case Rep. 2016;17:512-22.

Cappell MS, Edhi A, Amin M. Case report of primary intestinal lymphangiectasia diagnosed in an octogenarian by ileal intubation and by push enteroscopy after missed diagnosis by standard colonoscopy and EGD. Medicine (Baltimore). 2018;97(3):e9649.

Pops MA. Protein-losing gastroenteropathy. Calif Med. 1966;105(3):201-7.

Levitt DG, Levitt MD. Protein losing enteropathy: comprehensive review of the mechanistic association with clinical and subclinical disease states. Clin Exp Gastroenterol. 2017;10:147-68.

Carreño WD, Cardona LM, Barberi LE, Uribe MC. Linfangiectasia intestinal: Reporte de un caso. Revista Colombiana de Gastroenterologia. 2013;28(2):134-45.

A Case of Primary Intestinal Lymphangiectasia FAU - Won, Kyu Chang FAU - Jang, Byeong Ik FAU - Kim, Tae Nyeun FAU - Lee, Hyoung Woo FAU - Chung, Moon Kwan FAU - Lee, Hyun Woo. Korean J Intern Med. 1993;8(1):51-6.

Sun X, Shen W, Chen X, Wen T, Duan Y, Wang R. Primary intestinal lymphangiectasia: Multiple detector computed tomography findings after direct lymphangiography. Journal of Medical Imaging and Radiation Oncol. 2017;61(5):607-13.

Safatle-Ribeiro AV, Iriya K, Couto DS, Kawaguti FS, Retes F, Ribeiro Jr U, et al. Secondary Lymphangiectasia of the Small Bowel: Utility of Double Balloon Enteroscopy for Diagnosis and Management. Digestive Diseases. 2008;26(4):383-6.

Oh TG, Chung JW, Kim HM, Han SJ, Lee JS, Park JY, et al. Primary intestinal lymphangiectasia diagnosed by capsule endoscopy and double balloon enteroscopy. World J Gastrointest Endosc. 2011;3(11):235-40.

Takenaka H, Ohmiya N, Hirooka Y, Nakamura M, Ohno E, Miyahara R, et al. Endoscopic and Imaging Findings in Protein-losing Enteropathy. J clin gastroenterol. 2011;46(7):575-80.

Holt PR. Dietary Treatment of Protein Loss in Intestinal Lymphangiectasia. Pediatr. 1964 Nov 1;34(5):629-35.

Desai AP, Guvenc BH, Carachi R. Evidence for medium chain triglycerides in the treatment of primary intestinal lymphangiectasia. Eur J pediatr surgery. 2009 Aug;19(04):241-5.